Transcriptomic profiling has also identified early-stage RA biomarkers, such as CXCL10, MMP-3, IL-6, TNF, and S100A8/S100A9, that support early diagnosis and disease monitoring. This evidence concerns the gene TNF and rheumatoid arthritis.